Pernix Therapeutics reports loss

Pernix Therapeutics (Nasdaq: PTX) reported a loss for the first quarter of 42 cents per share compared with a loss of 62 cents per share in the year ago period as revenue fell. Shares of the specialty pharmaceutical tumbled 44 cents to $0.61.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.